BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2456432)

  • 1. Amelanotic melanoma: cases studied by Fontana stain, S-100 immunostain, and ultrastructural examination.
    Gibson LE; Goellner JR
    Mayo Clin Proc; 1988 Aug; 63(8):777-82. PubMed ID: 2456432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant melanoma with clinical and histologic features of Merkel cell carcinoma.
    House NS; Fedok F; Maloney ME; Helm KF
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 2):839-42. PubMed ID: 7525666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomorphology of metastatic melanoma--use of S-100 protein in the diagnosis of amelanotic melanoma.
    Kapila K; Kharbanda K; Verma K
    Cytopathology; 1991; 2(5):229-37. PubMed ID: 1782361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of subungual amelanotic malignant melanoma: an electron microscopic study of aberrant melanosomes.
    Matsuta M; Segawa I; Akasaka T; Kon S; Nara T; Minato S
    J Cutan Pathol; 1990 Aug; 17(4):246-50. PubMed ID: 2394867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.
    Thomas NE; Kricker A; Waxweiler WT; Dillon PM; Busman KJ; From L; Groben PA; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Orlow I; Paine S; Ollila DW; Reiner AS; Luo L; Hao H; Frank JS; Begg CB; Berwick M;
    JAMA Dermatol; 2014 Dec; 150(12):1306-314. PubMed ID: 25162299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical and histochemical tools in the diagnosis of amelanotic melanoma.
    van Duinen SG; Ruiter DJ; Hageman P; Vennegoor C; Dickersin GR; Scheffer E; Rümke P
    Cancer; 1984 Apr; 53(7):1566-73. PubMed ID: 6365305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-100 protein in amelanotic melanoma. A convenient immunocytochemical approach compared to electron microscopy.
    Jundt G; Schulz A; Paul E; Cochran AJ; Herschman HR
    Pathol Res Pract; 1986 Mar; 181(1):37-44. PubMed ID: 3517837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
    Kopera D; Hohenleutner U; Stolz W; Landthaler M
    Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
    de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
    Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural diagnosis of amelanotic malignant melanoma: aberrant melanosomes, myelin figures or lysosomes?
    Erlandson RA
    Ultrastruct Pathol; 1987; 11(2-3):191-208. PubMed ID: 3590351
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of clinically amelanotic malignant melanoma and assessment of its margins by in vivo confocal scanning laser microscopy.
    Busam KJ; Hester K; Charles C; Sachs DL; Antonescu CR; Gonzalez S; Halpern AC
    Arch Dermatol; 2001 Jul; 137(7):923-9. PubMed ID: 11453812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemistry of neurotropic melanoma.
    Warner TF; Lloyd RV; Hafez GR; Angevine JM
    Cancer; 1984 Jan; 53(2):254-7. PubMed ID: 6360335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural confirmation of malignant melanoma.
    Carstens PH; Kuhns JG
    Ultrastruct Pathol; 1981; 2(2):147-9. PubMed ID: 6168081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of some methods for identifying amelanotic and oligomelanotic melanoma metastases in paraffin sections.
    Palmer AA; Hall BE; Lew M
    Pathology; 1985 Apr; 17(2):335-9. PubMed ID: 3900899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features.
    Pizzichetta MA; Talamini R; Stanganelli I; Puddu P; Bono R; Argenziano G; Veronesi A; Trevisan G; Rabinovitz H; Soyer HP
    Br J Dermatol; 2004 Jun; 150(6):1117-24. PubMed ID: 15214897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pigmented pulmonary carcinoid tumor. An immunohistochemical and ultrastructural study.
    Gal AA; Koss MN; Hochholzer L; DeRose PB; Cohen C
    Arch Pathol Lab Med; 1993 Aug; 117(8):832-6. PubMed ID: 7688214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postembedding immunogold electron microscopy for S100, tubulin, and cytoskeletal proteins in an amelanotic malignant melanoma.
    Hearn SA; Kontozoglou TE
    Mod Pathol; 1989 Jan; 2(1):46-54. PubMed ID: 2922390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic diversity in malignant melanomas.
    Nakhleh RE; Wick MR; Rocamora A; Swanson PE; Dehner LP
    Am J Clin Pathol; 1990 Jun; 93(6):731-40. PubMed ID: 2346132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural aspects of melanization of hamster Ab amelanotic melanoma in primary cell culture.
    Bomirski A; Słomiński A
    Acta Derm Venereol; 1986; 66(6):520-3. PubMed ID: 2433873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of S-100 versus hematoxylin and eosin staining for evaluating dermal invasion and peripheral margins by desmoplastic malignant melanoma.
    Eng W; Tschen JA
    Am J Dermatopathol; 2000 Feb; 22(1):26-9. PubMed ID: 10698212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.